The gaps that delay patient access sit between departments, not inside them.
A healthcare or life sciences product moves through marketing, market access, regulatory affairs, supply and logistics, pharmacovigilance, compliance, and quality. Each function runs its own tools, its own timelines, and its own interpretation of the rules.
Delays rarely start inside a function. They start at the handover: a regulatory decision that supply planning never sees, a pricing assumption that market access cannot trace, a safety finding that never reaches the commercial team.
This is the structural flaw HERMS was built to address. Instead of optimising one department, the HERMS platform connects seven functions on one intelligence layer, so a change in one place is visible, assessed, and acted on everywhere it matters.
The result is not another dashboard. It is a single governed view of how a product actually moves through the region, with every decision traceable to its source.
Fragmentation is the problem. One connected ecosystem is the answer.